$1.72
-0.03-1.71%
At close: -
$1.87
0.158.65%
After Hours: Mar 25, 9:05 AM EDT
Comments
Loading...
Lexaria Bioscience Earnings Estimates, EPS & Revenue | NASDAQ:LEXX | Benzinga
Lexaria Bioscience reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Jan 10
EPS
$-0.160
Quarterly Revenue
$183.92K
Annual Revenue
(as of Nov 30)
(as of Nov 30)
$496.92K
Analyze the earnings history of Lexaria Bioscience using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LEXX | Lexaria Bioscience | -$0.06 | — | — | — | $145.00K | $100.00K | — | — | 04/08/2025 | Get Alert |
| LEXX | Lexaria Bioscience | -$0.13 | -$0.12 | -$0.16 | -33.33% | $151.28K | $100.00K | $183.92K | 83.92% | 01/10/2025 | Get Alert |
| LEXX | Lexaria Bioscience | -$0.12 | -$0.11 | -$0.15 | -36.36% | $0.00 | $150.00K | $84.00K | -44.00% | 11/26/2024 | Get Alert |
| LEXX | Lexaria Bioscience | -$0.37 | -$0.10 | -$0.13 | -30.00% | $77.71K | $150.00K | $84.00K | -44.00% | 07/12/2024 | Get Alert |
| LEXX | Lexaria Bioscience | -$0.22 | -$0.10 | -$0.06 | 40.00% | $35.02K | — | $145.00K | — | 04/09/2024 | Get Alert |
| LEXX | Lexaria Bioscience | -$0.30 | — | -$0.13 | — | $101.48K | — | $151.28K | — | 01/12/2024 | Get Alert |
| LEXX | Lexaria Bioscience | -$0.24 | -$0.13 | -$0.12 | 7.69% | $111.15K | $170.00K | $0.00 | -100.00% | 11/20/2023 | Get Alert |
| LEXX | Lexaria Bioscience | -$0.41 | — | -$0.37 | — | $99.72K | — | $93.15K | — | 07/14/2023 | Get Alert |
| LEXX | Lexaria Bioscience | -$0.25 | — | -$0.22 | — | $30.65K | — | $35.02K | — | 04/14/2023 | Get Alert |
| LEXX | Lexaria Bioscience | -$0.35 | — | -$0.30 | — | $13.88K | — | $101.48K | — | 01/17/2023 | Get Alert |
| LEXX | Lexaria Bioscience | -$0.25 | -$0.21 | -$0.24 | -14.29% | $31.02K | — | $111.15K | — | 11/28/2022 | Get Alert |
| LEXX | Lexaria Bioscience | -$0.40 | -$0.21 | -$0.41 | -95.24% | $204.06K | — | $99.72K | — | 07/14/2022 | Get Alert |
| LEXX | Lexaria Bioscience | -$0.27 | — | -$0.25 | — | $192.01K | — | $30.65K | — | 04/11/2022 | Get Alert |
| LEXX | Lexaria Bioscience | -$0.24 | — | -$0.35 | — | $295.66K | — | $13.88K | — | 01/14/2022 | Get Alert |
| LEXX | Lexaria Bioscience | — | — | -$0.25 | — | — | — | $31.02K | — | 11/29/2021 | Get Alert |
| LEXX | Lexaria Bioscience | — | — | -$0.40 | — | — | — | $204.06K | — | 07/15/2021 | Get Alert |
| LEXX | Lexaria Bioscience | — | — | -$0.27 | — | — | — | $192.01K | — | 04/14/2021 | Get Alert |
| LEXX | Lexaria Bioscience | — | — | -$0.24 | — | — | — | $295.66K | — | 01/14/2021 | Get Alert |
Lexaria Bioscience (LEXX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-01-10 | $-0.16 | $-0.12 | -33.3 % |
| Q4 | 2024-11-26 | $-0.15 | $-0.11 | -36.4 % |
| Q3 | 2024-07-12 | $-0.13 | $-0.10 | -30.0 % |
| Q2 | 2024-04-09 | $-0.06 | $-0.10 | 40.0 % |
Lexaria Bioscience (LEXX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-01-10 | $183.92K | $100.00K | 83.9 % |
| Q4 | 2024-11-26 | $84.00K | $150.00K | -44.0 % |
| Q3 | 2024-07-12 | $84.00K | $150.00K | -44.0 % |
| Q4 | 2023-11-20 | $0 | $170.00K | -100.0 % |
FAQ
When is Lexaria Bioscience (NASDAQ:LEXX) reporting earnings?
Lexaria Bioscience (LEXX) is scheduled to report earnings on April 8, 2025. The last reported earnings were for reported on January 10, 2025 for Q1.
What were the latest earnings per share (EPS) for Lexaria Bioscience (NASDAQ:LEXX)?
The Actual EPS was $-0.16, which missed the estimate of $-0.12.
What were Lexaria Bioscience’s (NASDAQ:LEXX) revenues?
The Actual Revenue was $183.9K, which beat the estimate of $100K.
Browse earnings estimates, EPS, and revenue on all stocks.